<DOC>
	<DOC>NCT00752596</DOC>
	<brief_summary>This is an open-label, long term compassionate use study of 125 mg per day of azimilide 2HCl in a patient who completed two other protocols (2000098 and 2001060.</brief_summary>
	<brief_title>Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Azimilide</mesh_term>
	<criteria>No inclusion criteria as the patient to be included is this compassionate use protocol is currently receiving azimilide therapy Currently taking Class I or other Class III antiarrhythmic drug or other drugs that may prolong QT interval. Is unwilling or unable to give or understand informed consent.</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>patients</keyword>
	<keyword>with ICD</keyword>
</DOC>